BioElectronics’ President Discusses ActiPatch’s® Opioid Application

PHOENIX, Sept. 11, 2018 (GLOBE NEWSWIRE) — President of BioElectronics Corporation (OTC Pink:BIEL) (“the Company”) goes back onto the “Stock Day” podcast. BioElectronics Corporation is a leader in non-invasive electroceuticals and the maker of the unique product line of disposable, drug-free, pain therapy devices: ActiPatch® Therapy, over-the-counter treatment for back pain and other musculoskeletal complaints; … Continue Reading

BioElectronics Applies for FDA’s Opioid Alternative Innovation Challenge Program

FREDERICK, MD, Aug. 13, 2018 (GLOBE NEWSWIRE) — BioElectronics Corporation (OTC PINK: BIEL), www.bielcorp.com, is pleased to announce that it has submitted an application to the U.S. Food and Drug Administration’s 2018 Opioid Innovation Challenge. This challenge was designed by the FDA to spur the development/deployment of medical devices that can help combat the opioid … Continue Reading

BioElectronics ActiPatch Musculoskeletal Therapy Added to Mundipharma Australia’s Pain Portfolio

FREDERICK, MD, July 23, 2018 (GLOBE NEWSWIRE) — BioElectronics Corporation (OTC PINK: BIEL), www.bielcorp.com is pleased to announce that Mundipharma Pty Limited (Mundipharma), https://www.mundipharma.com.au/ has added ActiPatch® to its pain management portfolio, by acquiring the exclusive Australian and New Zealand distribution rights to the ActiPatch® Musculoskeletal Pain Therapy medical device. “The addition of ActiPatch® to our existing pain medications … Continue Reading

BioElectronics Files FDA Application for Treatment of Musculoskeletal Pain

FREDERICK, MD, July 12, 2018 (GLOBE NEWSWIRE) — BioElectronics Corporation (OTC PINK: BIEL), www.bielcorp.com is pleased to announce that a Traditional 510(k) Premarket Notification for ActiPatch® was filed today with the U.S. Food and Drug Administration (FDA). The market clearance requested was “over-the-counter adjunctive use in the treatment of musculoskeletal pain”. While ActiPatch is already FDA-cleared for … Continue Reading

BioElectronics Corporation’s President Andy Whelan Joins Everett Jolly on “Stock Day” to Discuss Progress

PHOENIX, June 13, 2018 (GLOBE NEWSWIRE) — Uptick Newswire welcomed Andy Whelan, President of BioElectronics Corporation (OTC Pink:BIEL) (“the Company”) back onto the “Stock Day” podcast. Andy spoke with Everett about their progress in the US market, UK market, the new product, the US FDA, and new distributors and potential partnership opportunities. BioElectronics Corporation is … Continue Reading